Trump Administration Tries Again to Institute Rebates in 340B

Trump’s 340B Proposal Puts Patients Over Criminals and Big Hospital Profits

President Trump and his administration deserve thanks for putting patients ahead of Big Hospital profits.

Trump administration revises rebate pilot for 340B drug discount program, angering hospitals

Hospitals and clinics argue they already face thin or negative operating margins and the pilot will cause enormous financial strain.

Trump administration tries again to institute rebates in 340B

The Health Resources and Services Administration is again pushing to include rebates in the drug discount program after a failed attempt earlier this year. Hospitals railed against the announcement, saying it would burden already strapped providers.

HHS announces revised 340B Rebate Model Pilot Program; see AHA’s statement shared with media

The Department of Health and Human Services today issued a notice announcing a revised 340B Rebate Model Pilot Program, allowing qualifying drug manufacturers to use rebates rather than upfront discounts to effectuate the 340B ceiling price for certain drugs purchased by 340B covered entities. In a statement shared with the media, AHA President and CEO Rick Pollack said, “The AHA is deeply concerned that HHS has chosen to move forward with a 340…

Pharma groups back changes to 340B rebate pilot as earlier version remains stuck in court

HHS' Health Resources and Services Administration unveiled details of a revised 340B rebate pilot, which will let some drug manufacturers deny rebates for a small subset of drugs. The 340B program gives some hospitals access ...

How hospitals can prepare for heightened 340B oversight

Momentous change may be looming for the 340B Drug Pricing Program, currently managed by the Health Resources & Services Administration (HRSA). An ongoing debate regarding the program’s effectiveness reflects broad concerns regarding transparency, oversight and program integrity. At the center of the debate are questions about implementation of HRSA’s 340B Rebate Model Pilot Program. Although a federal court decision on Dec. 29, 2025, paused the …